NSE BSE
shilpa medicare ltd stock

SHILPA MEDICARE LTD Share Price

- - (%)
- NSE: SHILPAMED

SHILPA MEDICARE LTD Share Price Update

As of the latest trading session, SHILPA MEDICARE LTD share price is currently at 646.1, which is down by -1.80 from its previous closing. Today, the stock has fluctuated between 630.00 and 653.00. Over the past year, SHILPA MEDICARE LTD has achieved a return of 105.29 %. In the last month alone, the return has been 20.88 %. Read More...

SHILPA MEDICARE LTD Performance

Day Range

Low630.00 High653.00
646.10

52 Week Range

Low 296.80 High 685.00
646.10

SHILPA MEDICARE LTD Share Price

17752

530549

SHILPAMED

img img img img
No Data Available

Open Price

647.00

Prev. Close

647.90

Volume (Shares)

170691.00

Total traded value

1102.83

Upper Circuit

777.45

Lower Circuit

518.35

Note: The current prices & values are delayed, Login to your account for live updates.

SHILPA MEDICARE LTD Fundamentals


(Standalone)

Market Cap (Cr) 5608.27
PE Ratio (TTM) 234.93
Book Value / Share 270.24
Beta 0.88
ROE 3.49%
EPS (TTM) 3.51
Dividend Yield 0.00%
Net Profit Qtr (Cr) 9.74

SHILPA MEDICARE LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 87.45
Operating Expense 95.49
Net Profit 9.74
Net Profit Margin (%) 11.13
Earnings Per Share (EPS) 1.12
EBITDA 26.43
Effective Tax Rate (%) 14.78
Particulars DEC 2023 (Values in Cr)
Revenue 63.98
Operating Expense 82.28
Net Profit 2.70
Net Profit Margin (%) 4.22
Earnings Per Share (EPS) 0.31
EBITDA 18.91
Effective Tax Rate (%) 30.94
Particulars SEP 2023 (Values in Cr)
Revenue 74.61
Operating Expense 85.16
Net Profit 6.60
Net Profit Margin (%) 8.84
Earnings Per Share (EPS) 0.76
EBITDA 29.84
Effective Tax Rate (%) 44.95
Particulars JUN 2023 (Values in Cr)
Revenue 83.74
Operating Expense 87.43
Net Profit 7.90
Net Profit Margin (%) 9.43
Earnings Per Share (EPS) 0.91
EBITDA 29.78
Effective Tax Rate (%) 26.57
Particulars MAR 2023 (Values in Cr)
Revenue 66.50
Operating Expense 98.85
Net Profit -28.93
Net Profit Margin (%) -43.50
Earnings Per Share (EPS) -3.33
EBITDA -8.39
Effective Tax Rate (%) -7.18
Particulars MAR 2024 (Values in Cr)
Revenue 309.79
Operating Expense 350.37
Net Profit 26.94
Net Profit Margin (%) 8.69
Earnings Per Share (EPS) 3.10
EBITDA 104.96
Effective Tax Rate (%) 29.27
Particulars MAR 2023 (Values in Cr)
Revenue 247.70
Operating Expense 359.08
Net Profit 57.19
Net Profit Margin (%) 23.08
Earnings Per Share (EPS) 6.59
EBITDA 9.09
Effective Tax Rate (%) 15.08
Particulars MAR 2022 (Values in Cr)
Revenue 356.95
Operating Expense 379.13
Net Profit 140.99
Net Profit Margin (%) 39.49
Earnings Per Share (EPS) 16.87
EBITDA 71.36
Effective Tax Rate (%) 26.66
Particulars MAR 2021 (Values in Cr)
Revenue 257.05
Operating Expense 252.03
Net Profit 184.39
Net Profit Margin (%) 71.73
Earnings Per Share (EPS) 7.98
EBITDA 118.56
Effective Tax Rate (%) 27.84
Particulars MAR 2020 (Values in Cr)
Revenue 805.97
Operating Expense 600.35
Net Profit 193.72
Net Profit Margin (%) 24.03
Earnings Per Share (EPS) 23.76
EBITDA 251.63
Effective Tax Rate (%) 20.79
Particulars MAR 2023 (Values in Cr)
Book Value / Share 205.44
ROE % -1.72
ROCE % 0.79
Total Debt to Total Equity 0.41
EBITDA Margin 11.03
Particulars MAR 2022 (Values in Cr)
Book Value / Share 209.93
ROE % 3.67
ROCE % 5.84
Total Debt to Total Equity 0.46
EBITDA Margin 19.49
Particulars MAR 2021 (Values in Cr)
Book Value / Share 181.37
ROE % 7.20
ROCE % 7.58
Total Debt to Total Equity 0.44
EBITDA Margin 23.38
Particulars MAR 2020 (Values in Cr)
Book Value / Share 163.06
ROE % 12.23
ROCE % 12.04
Total Debt to Total Equity 0.23
EBITDA Margin 26.04
Particulars MAR 2019 (Values in Cr)
Book Value / Share 146.89
ROE % 8.15
ROCE % 8.53
Total Debt to Total Equity 0.17
EBITDA Margin 21.63
Particulars MAR 2023 (Values in Cr)
Book Value / Share 243.96
ROE % 3.49
ROCE % -0.84
Total Debt to Total Equity 0.12
EBITDA Margin 10.08
Particulars MAR 2022 (Values in Cr)
Book Value / Share 237.97
ROE % 7.17
ROCE % 1.10
Total Debt to Total Equity 0.23
EBITDA Margin 17.57
Particulars MAR 2021 (Values in Cr)
Book Value / Share 200.89
ROE % 8.93
ROCE % 2.09
Total Debt to Total Equity 0.33
EBITDA Margin 25.61
Particulars MAR 2020 (Values in Cr)
Book Value / Share 178.27
ROE % 14.17
ROCE % 14.53
Total Debt to Total Equity 0.21
EBITDA Margin 34.39
Particulars MAR 2019 (Values in Cr)
Book Value / Share 157.19
ROE % 10.18
ROCE % 11.59
Total Debt to Total Equity 0.15
EBITDA Margin 29.92
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 21.56
Total Assets 2902.38
Total Liabilities 2902.38
Total Equity 1774.35
Share Outstanding 86801898
Price to Book Ratio 0.94
Return on Assets (%) -1.11
Return on Capital (%) -1.26
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 34.11
Total Assets 2875.49
Total Liabilities 2875.49
Total Equity 1811.14
Share Outstanding 86801898
Price to Book Ratio 1.67
Return on Assets (%) 2.10
Return on Capital (%) 2.43
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 123.10
Total Assets 2632.36
Total Liabilities 2632.36
Total Equity 1467.49
Share Outstanding 81526899
Price to Book Ratio 1.66
Return on Assets (%) 5.61
Return on Capital (%) 6.39
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 44.56
Total Assets 1989.20
Total Liabilities 1989.20
Total Equity 1321.45
Share Outstanding 81526899
Price to Book Ratio 1.37
Return on Assets (%) 7.85
Return on Capital (%) 9.45
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 94.53
Total Assets 1610.02
Total Liabilities 1610.02
Total Equity 1189.96
Share Outstanding 81526899
Price to Book Ratio 2.16
Return on Assets (%) 6.97
Return on Capital (%) 8.27
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 4.82
Total Assets 2517.35
Total Liabilities 2517.35
Total Equity 2117.58
Share Outstanding 86801898
Price to Book Ratio 0.94
Return on Assets (%) 2.27
Return on Capital (%) 2.38
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 15.83
Total Assets 2896.11
Total Liabilities 2896.11
Total Equity 2065.66
Share Outstanding 86801898
Price to Book Ratio 1.67
Return on Assets (%) 4.86
Return on Capital (%) 6.24
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 115.27
Total Assets 2517.39
Total Liabilities 2517.39
Total Equity 1637.83
Share Outstanding 81526899
Price to Book Ratio 1.66
Return on Assets (%) 7.32
Return on Capital (%) 8.05
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 28.18
Total Assets 2021.28
Total Liabilities 2021.28
Total Equity 1453.42
Share Outstanding 81526899
Price to Book Ratio 1.37
Return on Assets (%) 9.58
Return on Capital (%) 10.92
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 90.92
Total Assets 1668.28
Total Liabilities 1668.28
Total Equity 1281.54
Share Outstanding 81526899
Price to Book Ratio 2.16
Return on Assets (%) 7.43
Return on Capital (%) 8.61
Particulars MAR 2023 (Values in Cr)
Net Income -38.27
Cash from Operations 258.54
Cash from Investing -278.48
Cash from Financing 45.79
Net change in Cash -6.51
Free Cash Flow 531.08
Particulars MAR 2022 (Values in Cr)
Net Income 102.26
Cash from Operations 139.61
Cash from Investing -285.49
Cash from Financing 82.85
Net change in Cash -97.50
Free Cash Flow 471.44
Particulars MAR 2021 (Values in Cr)
Net Income 195.05
Cash from Operations 94.52
Cash from Investing -404.27
Cash from Financing 436.37
Net change in Cash 79.02
Free Cash Flow 448.77
Particulars MAR 2020 (Values in Cr)
Net Income 188.05
Cash from Operations 166.57
Cash from Investing -289.51
Cash from Financing 175.50
Net change in Cash 10.36
Free Cash Flow 515.85
Particulars MAR 2019 (Values in Cr)
Net Income 135.67
Cash from Operations 182.84
Cash from Investing -196.16
Cash from Financing 10.05
Net change in Cash -39.32
Free Cash Flow 263.55
Particulars MAR 2023 (Values in Cr)
Net Income 12.67
Cash from Operations 10.49
Cash from Investing -94.79
Cash from Financing 87.67
Net change in Cash -5.03
Free Cash Flow 68.76
Particulars MAR 2022 (Values in Cr)
Net Income 192.89
Cash from Operations 208.36
Cash from Investing -378.97
Cash from Financing 97.22
Net change in Cash -107.87
Free Cash Flow 381.81
Particulars MAR 2021 (Values in Cr)
Net Income 255.53
Cash from Operations 112.97
Cash from Investing -238.13
Cash from Financing 255.57
Net change in Cash 87.07
Free Cash Flow 378.68
Particulars MAR 2020 (Values in Cr)
Net Income 233.98
Cash from Operations 170.64
Cash from Investing -295.09
Cash from Financing 170.10
Net change in Cash 4.80
Free Cash Flow 250.61
Particulars MAR 2019 (Values in Cr)
Net Income 155.59
Cash from Operations 199.60
Cash from Investing -214.70
Cash from Financing 8.16
Net change in Cash -42.38
Free Cash Flow 273.81
Company Name Price P/E P/B Market Cap 52 Week Low/High
SHILPA MEDICARE LTD 646.05 204.45 2.73 6317.78 296.45 / 685.00
BLISS GVS PHARMA LTD 114.00 12.46 1.23 1194.01 77.65 / 148.95
CIPLA LTD 1511.35 28.66 4.56 122044.23 1020.00 / 1581.70
FERMENTA BIOTECH LIMITED 213.15 0.00 2.16 627.32 136.60 / 219.05
GLAXOSMITHKLINE PHARMA LT 2611.55 67.38 24.88 44241.23 1376.50 / 2759.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
SHILPA MEDICARE LTD 646.05 184.06 2.39 6317.78 296.45 / 685.00
AMRUTAJAN HEALTH LTD 742.65 47.73 7.44 2147.05 556.05 / 826.00
ASTRAZENECA PHARMA IND LT 6566.50 109.81 23.05 16416.25 3715.05 / 7550.00
BLISS GVS PHARMA LTD 114.00 15.68 1.20 1194.01 77.65 / 148.95
ABBOTT INDIA LIMITED 28602.85 50.60 16.43 60781.06 21907.45 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 654.60
  • 26 Days 605.20
  • 10 Days 640.30
  • 50 Days 569.80
  • 12 Days 634.70
  • 100 Days 524.50
  • 20 Days 615.10
  • 200 Days 369.90
650.63
PIVOT
First Resistance 656.47
Second Resistance 665.03
Third Resistance 670.87
First Support 642.07
Second Support 636.23
Third Support 627.67
RSI 64.35
MACD 29.52
Commodity Channel Index (CCI) 72.74
ADX 49.65
Williams % R -28.77

Over 1 Month

down

20.88

Over 3 Months

down

19.87

Over 6 Months

down

96.78

Over 1 Year

down

105.29

Over 3 Years

down

2.30

Over 5 Years

down

12.56

SHILPA MEDICARE LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

SHILPA MEDICARE LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
41.5
Promoter Holdings
44.39
FII
9.08
DII
5.02
Promoter Shares(Pledge Percentage)
90.41
Name Category Shares Shares%
Vishnukant Chaturbhuj Bhutada Shareholding of Promoter and Promoter Group 6365610.0 6.51
Dharmavati Bhutada Shareholding of Promoter and Promoter Group 6207796.0 6.35
Ravi Kumar Innani Shareholding of Promoter and Promoter Group 4006370.0 4.1
Suraj Kumar Innani Shareholding of Promoter and Promoter Group 3980695.0 4.07
Om Prakash Inani Shareholding of Promoter and Promoter Group 2867691.0 2.93
Icici Prudential Pharma Healthcare And Diaganostic Public Shareholding 2762079.0 2.82
Deepak Kumar Innani Shareholding of Promoter and Promoter Group 2733960.0 2.8
Kantadevi Inani Shareholding of Promoter and Promoter Group 2540096.0 2.6
Pivotal Enterprises Private Limited Public Shareholding 2200000.0 2.25
Cohesion Mk Best Ideas Sub-trust Public Shareholding 2076137.0 2.12
Madhav Vishnukant Bhutada Shareholding of Promoter and Promoter Group 2000000.0 2.05
Keshav Bhutada Shareholding of Promoter and Promoter Group 2000000.0 2.05
Akash Bhanshali Public Shareholding 1600000.0 1.64
Bandhan Small Cap Fund Public Shareholding 1558455.0 1.59
Ramakant Innani Shareholding of Promoter and Promoter Group 1497778.0 1.53
Dovetail India Fund Class 6 Shares Public Shareholding 1486066.0 1.52
Vishnukanth C Bhutada (huf) Shareholding of Promoter and Promoter Group 1336130.0 1.37
Taradevi Innani Shareholding of Promoter and Promoter Group 1249998.0 1.28
Sbi Life Insurance Co. Ltd Public Shareholding 1225441.0 1.25
Vishnukanta Inani Shareholding of Promoter and Promoter Group 1212498.0 1.24
Elm Park Fund Limited Public Shareholding 1200000.0 1.23
Brijgopal Innani Shareholding of Promoter and Promoter Group 1174866.0 1.2
Natamal Innani Shareholding of Promoter and Promoter Group 1131232.0 1.16
Shakuntalabai Innani Shareholding of Promoter and Promoter Group 1129186.0 1.15
Sapphire Intrex Limited Public Shareholding 1066500.0 1.09
Viral Amal Parikh Public Shareholding 1000000.0 1.02
Sagar Innani Shareholding of Promoter and Promoter Group 1000000.0 1.02
Triveni Inani Shareholding of Promoter and Promoter Group 294810.0 0.3
Priya Innani Shareholding of Promoter and Promoter Group 180696.0 0.18
Kamalkishore Innani Shareholding of Promoter and Promoter Group 165236.0 0.17
Keerti Innani Shareholding of Promoter and Promoter Group 155021.0 0.16
Manjulatha Innani Shareholding of Promoter and Promoter Group 157546.0 0.16
Namrata Bhutada Shareholding of Promoter and Promoter Group 22500.0 0.02

SHILPA MEDICARE LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2022-09-19 1.1 Final 2022-09-20 Equity shares 2021-09-20 1.1 Final 2021-09-22 Equity shares 2020-03-16 1.1 Interim 2020-03-17 Equity shares 2019-09-12 1.0 Final 2019-09-14 Equity shares 2018-03-01 0.7 Interim 2018-03-05 Equity shares 2017-03-21 0.6 Interim 2017-03-22 Equity shares 2016-03-28 0.6 Interim 2016-03-29 Equity shares 2015-09-16 1.1 Final 2015-09-21 Equity shares 2014-09-11 1.0 Final 2014-09-13 Equity shares 2013-07-16 1.3 Final 2013-07-18 Equity shares 2012-09-17 0.9 Final 2012-09-19 Equity shares 2011-09-15 0.8 Final 2011-09-19 Equity shares 2010-09-16 0.7 Final 2010-09-20 Equity shares 2009-09-24 0.5 Final 2009-09-26 Equity shares 2008-09-11 0.4 Final 2008-09-15 Equity shares 2007-05-24 2.0 Interim 2007-05-26 Equity shares 2005-09-26 0.0 Final 2005-09-27 Equity shares
Ex-Date Ex-Bonus Ratio
2013-07-18 2013-07-16 1:2
Ex-Date Old FV NEW FV Record Date
2015-11-06 2.0 1.0 2015-11-09 2007-09-28 10.0 2.0 2007-10-08

Learn More About Stocks

About SHILPA MEDICARE LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by SHILPA MEDICARE LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Shilpa Medicare Ltd?

Answer Field

The share price of Shilpa Medicare Ltd for NSE is ₹ 646.1 and for BSE is ₹ 639.4.

What is the Market Cap of Shilpa Medicare Ltd?

Answer Field

The market cap of Shilpa Medicare Ltd for NSE is ₹ 5,608.27 Cr. and for BSE is ₹ 5,550.11 Cr. as of now.

What is the 52 Week High and Low of Shilpa Medicare Ltd?

Answer Field

The 52 Week High and Low of Shilpa Medicare Ltd for NSE is ₹ 685.00 and ₹ 296.80 and for BSE is ₹ 685.00 and ₹ 296.45.

How to Buy Shilpa Medicare Ltd share?

Answer Field

You can trade in Shilpa Medicare Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Shilpa Medicare Ltd?

Answer Field

The 1 year returns on the stock has been 105.29%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader